224 related articles for article (PubMed ID: 11060766)
1. D-Sotalol: death by the SWORD or deserving of further consideration for clinical use?
Doggrell SA; Brown L
Expert Opin Investig Drugs; 2000 Jul; 9(7):1625-34. PubMed ID: 11060766
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
Advani SV; Singh BN
Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
[TBL] [Abstract][Full Text] [Related]
3. Sotalol: a breakthrough antiarrhythmic?
Nappi JM; McCollam PL
Ann Pharmacother; 1993 Nov; 27(11):1359-68. PubMed ID: 8286812
[TBL] [Abstract][Full Text] [Related]
4. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
Fitton A; Sorkin EM
Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
[TBL] [Abstract][Full Text] [Related]
5. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.
Waldo AL; Camm AJ; deRuyter H; Friedman PL; MacNeil DJ; Pauls JF; Pitt B; Pratt CM; Schwartz PJ; Veltri EP
Lancet; 1996 Jul; 348(9019):7-12. PubMed ID: 8691967
[TBL] [Abstract][Full Text] [Related]
6. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Lazzara R
Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
[TBL] [Abstract][Full Text] [Related]
7. Sotalol: An important new antiarrhythmic.
Anderson JL; Prystowsky EN
Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
[TBL] [Abstract][Full Text] [Related]
8. Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?
Pratt CM; Camm AJ; Cooper W; Friedman PL; MacNeil DJ; Moulton KM; Pitt B; Schwartz PJ; Veltri EP; Waldo AL
Am J Cardiol; 1998 Apr; 81(7):869-76. PubMed ID: 9555777
[TBL] [Abstract][Full Text] [Related]
9. Proarrhythmic effects of DL- and D-sotalol on the "border zone" between normal and ischemic regions of isolated ventricular myocardium and antiarrhythmic effects on reperfusion.
Picard S; Rouet R; Monti F; Puddu PE; Ducouret P; Flais F; Libersa C; Gérard JL
J Cardiovasc Pharmacol; 1998 Jan; 31(1):126-39. PubMed ID: 9456287
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.
Singh BN
Am J Cardiol; 1993 Aug; 72(4):8A-18A. PubMed ID: 8346731
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
Kirschenbaum HL; Rosenberg JM
Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
[TBL] [Abstract][Full Text] [Related]
12. Sotalol for cardiac arrhythmias.
Med Lett Drugs Ther; 1993 Apr; 35(893):27-8. PubMed ID: 8450806
[No Abstract] [Full Text] [Related]
13. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Finance O; Manning A; Chatelain P
J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217
[TBL] [Abstract][Full Text] [Related]
15. Sotalol: a new class III antiarrhythmic agent.
Zanetti LA
Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605
[TBL] [Abstract][Full Text] [Related]
16. Sotalol in treatment of pediatric cardiac arrhythmias.
Celiker A; Ayabakan C; Ozer S; Ozme S
Pediatr Int; 2001 Dec; 43(6):624-30. PubMed ID: 11737739
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
Follath F; Candinas R; Frielingsdorf J
Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
[TBL] [Abstract][Full Text] [Related]
18. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.
Wang J; Feng J; Nattel S
Circulation; 1994 Oct; 90(4):2032-40. PubMed ID: 7923691
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.
Funck-Brentano C
Eur Heart J; 1993 Nov; 14 Suppl H():30-5. PubMed ID: 7904936
[TBL] [Abstract][Full Text] [Related]
20. Sotalol: a new agent for the treatment of ventricular arrhythmias.
Samoil D; Grubb BP; Temesy-Armos PN
Am J Med Sci; 1994 Jan; 307(1):49-53. PubMed ID: 8291508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
